tiprankstipranks
Sera Prognostics, Inc. (SERA)
:SERA
US Market
Holding SERA?
Track your performance easily

Sera Prognostics (SERA) Earnings Dates, Call Summary & Reports

72 Followers

Earnings Data

Report Date
Mar 19, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-0.24
Last Year’s EPS
-0.25
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 09, 2021
|
% Change Since: -26.54%
|
Next Earnings Date:Aug 30, 2021
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in clinical trial results, increased awareness and engagement, and a strong cash position. However, there were challenges such as decreased net revenue and increased operating expenses. The company is optimistic about future growth and is actively working on achieving the prerequisites for revenue expansion.
Company Guidance
During Sera Prognostics' Q3 2024 earnings call, the company emphasized its strategic initiatives to drive growth and improve maternal health outcomes. Key metrics highlighted included a net revenue of $29,000 for the quarter, compared to $42,000 in the same period last year, and total operating expenses of $8.9 million, up 8% from $8.2 million. The net loss for the quarter increased by 10% to $7.9 million, influenced primarily by higher stock compensation expenses. The company reported cash, cash equivalents, and available-for-sale securities of $74.3 million as of September 30, 2024, with projected year-end cash balance expected to be $68 million, providing runway into 2027 assuming no future revenue. Sera is focused on expanding test adoption through positive clinical trial publications, enhancing payer coverage, and boosting consumer awareness, exemplified by a 227% increase in website traffic year-over-year. The company is also advancing its commercialization efforts while maintaining careful expense management to support future revenue growth.
Successful AVERT PRETERM TRIAL Results
The AVERT PRETERM TRIAL results were published on the front cover of the July issue of the International peer-reviewed journal diagnostics, showing improved health risks of babies in asymptomatic pregnant mothers.
Increased Awareness and Engagement
The first email campaign had an open rate of 9%, the second 48%, and the third 70%, indicating effective engagement with medical professionals.
Significant Increase in Website Traffic
The preterm.com site saw a 227% traffic increase in September compared to last year, following the availability of the PreTRM Test for order online.
Strong Cash Position
As of September 30, 2024, the company had cash, cash equivalents, and available-for-sale securities of approximately $74.3 million, with a projected year-end cash balance of approximately $68 million.
---

Sera Prognostics (SERA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SERA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 30, 20212021 (Q2)
-0.18 / -3.17
-0.153-1971.90% (-3.02)
Nov 09, 20212021 (Q3)
-0.24 / -0.39
-0.165-136.36% (-0.23)
Mar 29, 20222021 (Q4)
-0.29 / -0.41
May 10, 20222022 (Q1)
-0.37 / -0.40
-0.17-135.29% (-0.23)
Aug 10, 20222022 (Q2)
-0.41 / -0.37
-3.1788.33% (+2.80)
Nov 09, 20222022 (Q3)
-0.56 / -0.35
-0.3910.26% (+0.04)
Mar 22, 20232022 (Q4)
-0.36 / -0.31
-0.4124.39% (+0.10)
May 10, 20232023 (Q1)
-0.38 / -0.34
-0.415.00% (+0.06)
Aug 09, 20232023 (Q2)
-0.36 / -0.34
-0.378.11% (+0.03)
Nov 08, 20232023 (Q3)
-0.34 / -0.23
-0.3534.29% (+0.12)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SERA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2024$8.74$7.63-12.70%
Aug 07, 2024$7.40$7.41+0.14%
May 08, 2024$9.30$9.79+5.27%
Mar 20, 2024$9.02$9.36+3.77%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Sera Prognostics, Inc. (SERA) report earnings?
Sera Prognostics, Inc. (SERA) is schdueled to report earning on Mar 19, 2025, TBA Not Confirmed.
    What is Sera Prognostics, Inc. (SERA) earnings time?
    Sera Prognostics, Inc. (SERA) earnings time is at Mar 19, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SERA EPS forecast?
          SERA EPS forecast for the fiscal quarter 2024 (Q4) is -0.24.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis